P3364
P3781
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaClinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal CancerFolfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerPreoperative Radiotherapy and E7046 in Rectum CancerFOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon CancerCombination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerA Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal CancerUracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal CancerFluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon CancerBevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCombination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryArsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to TreatmentStereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic CancerCombination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerAn Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric CancerMaintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal CancerChemotherapy for Relapsed Epstein Barr Virus Associated LymphomaFluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerHigh-Dose Methotrexate in Treating Young Patients With Solid TumorsCombination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryCombination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin LymphomaFOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerBortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaStudy of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) SubjectsA Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal CancerA Study of IMC-1121B (Ramucirumab) in Colorectal CancerRadiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerFolinic Acid in AutismFOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer PatientsNeoadjuvant Therapy Followed by Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Pancreatic CancerCombination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon CancerCombination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerIsolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaBortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach CancerCombination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic OsteosarcomaCombination Chemotherapy in Treating Patients With Advanced Cancer of the PancreasHigh-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaCombination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
P4844
Inhibitory effect of folinic acid on radiation-induced micronuclei and chromosomal aberrations in V79 cellsRapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer.Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trCytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).[Management of returned anti-neoplastic treatments and their reuse in oncology patients.].Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil.Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).Dose–Finding Study of 5’-Deoxy-5-Fluorouridine in Combination with Fixed Doses of Cisplatin and L -Folinic Acid for the Treatment of Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckEvaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: A first-line phase II studyCapillary electrophoresis quantitation of l-L-folinic acid in the presence of its inactive d-L-form
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Folinezuur
@nl
Folinska kiselina
@sh
Folinska kiselina
@sr-el
Folinsyre
@da
Levofolinsäure
@de
acide levofolinique
@fr
acido folinico
@it
asid ffolinig
@cy
foliinihappo
@fi
kwas (6S)-folinowy
@pl
type
label
Folinezuur
@nl
Folinska kiselina
@sh
Folinska kiselina
@sr-el
Folinsyre
@da
Levofolinsäure
@de
acide levofolinique
@fr
acido folinico
@it
asid ffolinig
@cy
foliinihappo
@fi
kwas (6S)-folinowy
@pl
altLabel
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
@en
(6S)-5-formyltetrahydrofolic acid
@en
(6S)-Folinic acid
@en
(6S)-Leucovorin
@cy
(6S)-Leucovorin
@en
(S)-Leucovorin
@cy
(S)-Leucovorin
@en
(S)-leukoworyna
@pl
1492-18-8
@fr
ATC kod V03AF06
@sr
prefLabel
Folinezuur
@nl
Folinska kiselina
@sh
Folinska kiselina
@sr-el
Folinsyre
@da
Levofolinsäure
@de
acide levofolinique
@fr
acido folinico
@it
asid ffolinig
@cy
foliinihappo
@fi
kwas (6S)-folinowy
@pl
P31
P638
P486
P592
P646
P661
P662
P683
P1579
P2017
C1[C@@H](N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
P2067
P2115
N0000177954
P2175
P231
68538-85-2
P233
C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
P234
1S/C20H23N7O7/c21-20-25-16-15( ...... 21,23,25,26,32)/t12-,13-/m0/s1